Interferon Beta: From Molecular Level to Therapeutic Effects

Area of Science:

• Immunology
• Biochemistry
• Pharmacology

Background:

• Interferon beta (IFNβ) is a naturally occurring cytokine with antiviral, antiproliferative, and immunomodulatory functions.
• It signals through the type I IFN receptor (IFNAR1/IFNAR2) and regulates gene expression via JAK/STAT pathways.
• IFNβ is therapeutically used for conditions like hepatitis C and multiple sclerosis.

Purpose of the Study:

• To review current knowledge on Interferon beta (IFNβ).
• To discuss IFNβ's structure, dynamics, signaling, mechanism of action, and therapeutic effects.
• To explore the relationship between IFNβ's structural properties and its immunogenicity.

Main Methods:

• Literature review of Interferon beta (IFNβ) research.
• Analysis of IFNβ's structural properties, including aggregation and epitopes.
• Examination of methods used to predict and reduce IFNβ immunogenicity.

Main Results:

• IFNβ exhibits pleiotropic activities, making it effective against various diseases.
• Antidrug antibodies can arise during IFNβ therapy, potentially reducing efficacy.
• Structural factors like aggregation and epitopes are critical determinants of IFNβ immunogenicity.

Conclusions:

• Knowledge of IFNβ structure and dynamics is crucial for understanding its therapeutic effects and immunogenicity.
• Addressing structural properties can lead to the development of safer and more effective IFNβ drug products.
• Further research into IFNβ immunogenicity is needed to optimize therapeutic strategies.